Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

🚨 The Cancer Dosing Protocol Big Pharma Will Never Fund Dr. William Makis shared a graph outlining an ivermectin dosing schedule for cancer. He suggests a starting dose of 1 mg/kg of body weight per day for many cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemia. For... someone weighing 60 kg, that equals 60 mg daily. Several doctors have reported individual cases: • A prostate cancer patient’s PSA dropped from 89 to 11 while taking 45 mg per day. • An ovarian cancer marker, CA125, fell from 288 to 22 at a dose of 0.2 mg per kg. • A study involving children with leukemia reported no side effects after six months at 1 mg per kg. For more aggressive cancers such as pancreatic or brain tumors, higher doses have been mentioned, up to 2 to 2.5 mg/kg per day, with temporary side effects reported in some cases. Dr. Makis states that ivermectin is generally considered a safe drug and suggests 1 mg per kg per day as a starting point in the cases he discusses. #Ivermectin #Cancer #CancerTreatment #cancercure #Makismdshow more

GENIX MEDS

14,626 subscribers

136,032 просмотров • 4 месяцев назад •via X (Twitter)

Здоровье и велнес Новости и политика Наука и технологии

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,014 просмотров • 1 месяц назад

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

19,733 просмотров • 25 дней назад

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) Side effects: No long-term side effects reported. Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day Best for: Starting dose for most cancers (lung, pancreatic, renal cell, gastric, etc.). Side effects: No long-term side effects reported. Example: Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day Best for: Very aggressive cancers (leukemia, pancreatic, brain cancers). Side effects: No long-term side effects reported. Example: Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Best for: Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. Side effects: Possible short-term & transient visual effects (usually resolve in a few days). Example: Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. Quick conversion example (for a 60 kg / 132 lb person): - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

Valerie Anne Smith

958,404 просмотров • 2 месяцев назад

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) Side effects: No long-term side effects reported. Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day Best for: Starting dose for most cancers (lung, pancreatic, renal cell, gastric, etc.). Side effects: No long-term side effects reported. Example: Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day Best for: Very aggressive cancers (leukemia, pancreatic, brain cancers). Side effects: No long-term side effects reported. Example: Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Best for: Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. Side effects: Possible short-term & transient visual effects (usually resolve in a few days). Example: Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. Quick conversion example (for a 60 kg / 132 lb person): - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

Dr. Zakaria MD

133,235 просмотров • 17 дней назад

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

PharmacyinUSA

50,388 просмотров • 1 месяц назад

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.

Commentary | Global Ivermectin Research Hub

101,262 просмотров • 3 месяцев назад

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. **The chart has been upscaled for better visibility** #Ivermectin #Fenbendazole #Mebendazole

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for: • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. The chart has been upscaled for better visibility #Ivermectin #Fenbendazole #Mebendazole

PharmacyinUSA

90,475 просмотров • 2 месяцев назад

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.

Camus

835,927 просмотров • 10 месяцев назад

🚨 DR. WILLIAM MAKIS MD CALLS THIS THE MOST IMPORTANT IVERMECTIN CANCER GRAPH HE'S EVER CREATED After reviewing hundreds of studies, case reports, and patient outcomes, Dr. William Makis MD says one question keeps coming up: ❓"What dose of Ivermectin are people actually using in cancer protocols?" His answer is surprisingly simple. 💊 For most cancers, his suggested starting point is: 1 mg/kg of Ivermectin per day 📊 THE FOUR IVERMECTIN DOSING LEVELS DR. MAKIS DISCUSSES MOST OFTEN 🔹 0.2 mg/kg daily Lower-dose protocols discussed in some case reports and published reports. 🔹 1.0 mg/kg daily Dr. Makis' typical starting point for most cancers. 🔹 2.0 mg/kg daily Discussed for highly aggressive cancers, including some brain cancers. 🔹 2.5 mg/kg daily The highest dosing level discussed in certain case reports. According to Dr. Makis, some of the most widely discussed case reports involve higher dosing strategies. And that's where the conversation gets interesting. Because this isn't being discussed for just one type of cancer. Researchers have investigated Ivermectin in: ✅ Breast Cancer ✅ Colon Cancer ✅ Lung Cancer ✅ Pancreatic Cancer ✅ Kidney Cancer ✅ Gastric Cancer ✅ Prostate Cancer ✅ Brain Cancer ✅ Leukemia And many others. Dr. Makis frequently points to reports involving significant changes in tumor markers, imaging results, and patient outcomes that continue driving interest in repurposed medicines. He also highlights something many people overlook: ✅ Off patent ✅ Generic ✅ Low cost ✅ Studied for decades Yet despite the growing number of publications and case reports, mainstream oncology rarely discusses it. That's why the debate keeps growing. Not because everyone agrees. Because patients keep sharing stories. Doctors keep debating. Researchers keep publishing. And people keep asking questions. Because if the answer were obvious... The conversation would've ended years ago. Instead, it's getting bigger. 📌 Save this chart. You'll want it later. 🔄 Repost so others can review the information for themselves. 💬 Have you been following Dr. William Makis MD's work on Ivermectin and cancer? 💊 Researching Ivermectin? Explore RXMEDS.STORE. #Ivermectin #CancerResearch #MakisMD #RepurposedDrugs

🚨 DR. WILLIAM MAKIS MD CALLS THIS THE MOST IMPORTANT IVERMECTIN CANCER GRAPH HE'S EVER CREATED After reviewing hundreds of studies, case reports, and patient outcomes, Dr. William Makis MD says one question keeps coming up: ❓"What dose of Ivermectin are people actually using in cancer protocols?" His answer is surprisingly simple. 💊 For most cancers, his suggested starting point is: 1 mg/kg of Ivermectin per day 📊 THE FOUR IVERMECTIN DOSING LEVELS DR. MAKIS DISCUSSES MOST OFTEN 🔹 0.2 mg/kg daily Lower-dose protocols discussed in some case reports and published reports. 🔹 1.0 mg/kg daily Dr. Makis' typical starting point for most cancers. 🔹 2.0 mg/kg daily Discussed for highly aggressive cancers, including some brain cancers. 🔹 2.5 mg/kg daily The highest dosing level discussed in certain case reports. According to Dr. Makis, some of the most widely discussed case reports involve higher dosing strategies. And that's where the conversation gets interesting. Because this isn't being discussed for just one type of cancer. Researchers have investigated Ivermectin in: ✅ Breast Cancer ✅ Colon Cancer ✅ Lung Cancer ✅ Pancreatic Cancer ✅ Kidney Cancer ✅ Gastric Cancer ✅ Prostate Cancer ✅ Brain Cancer ✅ Leukemia And many others. Dr. Makis frequently points to reports involving significant changes in tumor markers, imaging results, and patient outcomes that continue driving interest in repurposed medicines. He also highlights something many people overlook: ✅ Off patent ✅ Generic ✅ Low cost ✅ Studied for decades Yet despite the growing number of publications and case reports, mainstream oncology rarely discusses it. That's why the debate keeps growing. Not because everyone agrees. Because patients keep sharing stories. Doctors keep debating. Researchers keep publishing. And people keep asking questions. Because if the answer were obvious... The conversation would've ended years ago. Instead, it's getting bigger. 📌 Save this chart. You'll want it later. 🔄 Repost so others can review the information for themselves. 💬 Have you been following Dr. William Makis MD's work on Ivermectin and cancer? 💊 Researching Ivermectin? Explore RXMEDS.STORE. #Ivermectin #CancerResearch #MakisMD #RepurposedDrugs

RXMEDS.STORE

48,417 просмотров • 24 дней назад

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

RXMEDS.STORE

36,776 просмотров • 1 месяц назад

22 Year Old With Stage 4 Turbo Cancer Post Covid "Vax" Has Major Improvement From Ivermectin and Fenbendazole‼️ Dr. William Makis, a Canadian Oncologist, shares another success story of Ivermectin overcoming stage 4 turbo cancer in a 22 year old by taking 18 mg Ivermectin tablets daily for 19 days‼️ "Another IVERMECTIN + FENBENDAZOLE success story in Alberta where AHS Cancer Care has FAILED‼️ Turbo Cancer (Stage 4 Renal Carcinoma). "There is tremendous amount of Evidence that high dose Ivermectin is extremely effective in Treating many types of Cancers"‼️🙏👇 Credit 👉Dr. Makis💫👇👇 Full Podcast🔗👇👇

22 Year Old With Stage 4 Turbo Cancer Post Covid "Vax" Has Major Improvement From Ivermectin and Fenbendazole‼️ Dr. William Makis, a Canadian Oncologist, shares another success story of Ivermectin overcoming stage 4 turbo cancer in a 22 year old by taking 18 mg Ivermectin tablets daily for 19 days‼️ "Another IVERMECTIN + FENBENDAZOLE success story in Alberta where AHS Cancer Care has FAILED‼️ Turbo Cancer (Stage 4 Renal Carcinoma). "There is tremendous amount of Evidence that high dose Ivermectin is extremely effective in Treating many types of Cancers"‼️🙏👇 Credit 👉Dr. Makis💫👇👇 Full Podcast🔗👇👇

Sophia Dahl

130,241 просмотров • 1 год назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,473 просмотров • 1 год назад

🚨He Took Ivermectin for 8 Weeks. His PSA Dropped Fast “Ivermectin? That’s crazy. You shouldn’t talk about that publicly.” Fast forward ⬇️ A 76 year old military veteran. Diagnosed with prostate cancer, Gleason 7. He didn’t start chemo. He didn’t start radiation. He started 12 mg of ivermectin daily. Eight weeks later, he waited. At 12 weeks, doctors ordered a special PET scan focused on prostate abnormalities. His PSA told the same story. • Before: 12.6 • After: 5.3 Ivermectin really works and if used correctly, It can "CURE CANCER" For those who're looking forward to buy Ivermectin, Fenbendazole and Mebendazole then visit GENIX MEDS to get them at an affordable rate without any Rx. #ivermectin #CancerAwareness #Joerogan #Cancercure

🚨He Took Ivermectin for 8 Weeks. His PSA Dropped Fast “Ivermectin? That’s crazy. You shouldn’t talk about that publicly.” Fast forward ⬇️ A 76 year old military veteran. Diagnosed with prostate cancer, Gleason 7. He didn’t start chemo. He didn’t start radiation. He started 12 mg of ivermectin daily. Eight weeks later, he waited. At 12 weeks, doctors ordered a special PET scan focused on prostate abnormalities. His PSA told the same story. • Before: 12.6 • After: 5.3 Ivermectin really works and if used correctly, It can "CURE CANCER" For those who're looking forward to buy Ivermectin, Fenbendazole and Mebendazole then visit GENIX MEDS to get them at an affordable rate without any Rx. #ivermectin #CancerAwareness #Joerogan #Cancercure

GENIX MEDS

91,582 просмотров • 5 месяцев назад

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

159,980 просмотров • 1 год назад

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness

Ivermectin, Mebendazole, Fenbendazole BREAKING NEWS: First-in-the-World Ivermectin, Mebendazole, and Fenbendazole Protocol in Cancer Has Been Peer-Reviewed and Published on Sep. 19, 2024! Cancer researcher: IVERMECTIN can overcome chemotherapy resistance of TURBO CANCERS caused by mRNA vaccines: IVERMECTIN should be given to ALL Advanced Breast Cancer patients – outperforms chemo Paclitaxel & kills Cancer Stem Cells! 🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸🌼🌸 🚨BREAST CANCER = PARASITES🚨MAMOGRAPHY IS THE BIGGEST ORGANIZED CRIME AGAINST WOMEN!! Women who go for mammograms are probably unaware of the harm they do to themselves 😩 A few details to consider before deciding on a review: ✅ 50-60% of the “positive” results are incorrect!! So, being diagnosed with “breast cancer” in 50-60% of cases, turns out it didn’t exist at all!! ✅ during examination, the breast is pressed with a large weight of 10kPa (1019 kg / m2) and then healthy, very sensitive, milk gland tissue is bombarded by radioactive rays!! ✅ stimulates tumor growth and the spread of metastases!! ✅ study done on 690,000 records showed that completely healthy women have developed breast cancer in a large number of cases after mammographic examinations!! MakisMD Elon Musk Donald J. Trump #Ivermectin #CancerAwareness

skymeds store | Online Ivermectin Pharmacy

3,350,823 просмотров • 1 год назад

🚨 SHOCKING BOMBSHELL: They’ve been hiding this from you. Dr. Peter McCullough just exposed it in this video: A new real-world study of 197 cancer patients treated with low-dose Ivermectin (25 mg) + Mebendazole (250 mg). After just 6 months: 84.4% had clinical benefit 48.4% had tumor reduction or no detectable disease 86.9% completed treatment with only mild side effects Patients got scans every 3 months. Dr. McCullough breaks it down: tiny doses, massive results, and almost no downside. This is what the cancer industry and Big Pharma fear most — cheap, repurposed drugs actually working while they push trillion-dollar chemo and endless “treatments.” Cancer isn’t being cured because it’s too profitable.

🚨 SHOCKING BOMBSHELL: They’ve been hiding this from you. Dr. Peter McCullough just exposed it in this video: A new real-world study of 197 cancer patients treated with low-dose Ivermectin (25 mg) + Mebendazole (250 mg). After just 6 months: 84.4% had clinical benefit 48.4% had tumor reduction or no detectable disease 86.9% completed treatment with only mild side effects Patients got scans every 3 months. Dr. McCullough breaks it down: tiny doses, massive results, and almost no downside. This is what the cancer industry and Big Pharma fear most — cheap, repurposed drugs actually working while they push trillion-dollar chemo and endless “treatments.” Cancer isn’t being cured because it’s too profitable.

Dr. Dawn Michael

113,407 просмотров • 5 дней назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." Follow me for more Bombshell. #Fenbendazole #Ivermectin #Cancercure

Dr. Zakaria MD

44,317 просмотров • 2 дней назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with Seth Holehouse () posted to Rumble on November 21, 2025. ----------------Partial transcription of clip--------------- "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases."

Sense Receptor

227,993 просмотров • 7 месяцев назад

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

PharmacyinUSA

44,109 просмотров • 10 дней назад

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

166,528 просмотров • 7 месяцев назад